Portolan Capital Management, LLC Pure Tech Health PLC Transaction History

Portolan Capital Management, LLC

  • $1.26 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$23.7 - $42.0 $136,251 - $241,458
-5,749 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$35.0 - $51.64 $1.63 Million - $2.41 Million
-46,672 Reduced 89.03%
5,749 $213,000
Q3 2021

Nov 15, 2021
BUY
$43.2 - $53.44 $2.26 Million - $2.8 Million
52,421 New
52,421 $2.52 Million

Others Institutions Holding PRTC

# of Institutions
5
Shares Held
28.7K
Call Options Held
0
Put Options Held
0
View Full List

About PureTech Health plc

PRTC Quotes by TradingView
  • Ticker PRTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,888,500
  • Market Cap $566M
  • Description
  • PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...
More about PRTC
Track This Portfolio

Track Portolan Capital Management, LLC Portfolio

Follow Portolan Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Portolan Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email